Product Images Atorvastatin Calcium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Atorvastatin Calcium NDC 70934-482 by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label - 70934 482 96 Master Bottle Label Approval Rev A 04 20

Label - 70934 482 96 Master Bottle Label Approval   Rev A 04 20

This is a description of the medication Atorvastatin Calcium Tablets, which is available only with a prescription (Rx Only). The tablets come in a pack of 20 and have either 10mg or 20mg potency. The NDC (National Drug Code) for the medication is 70934-482.96, and the IR (Immediate Release) number is 5523 106. No other relevant information is available due to the text being partially unreadable.*

atorvastatin-fig-1 - atorvastatin fig 1

atorvastatin-fig-1 - atorvastatin fig 1

This is a chart showing the cumulative incidence in percentages for Atorastatn and Placsbo over a period of 35 years. The chart shows that Atorastatn has a lower incidence rate compared to Placsbo with a hazard ratio of 0.64 and p-value of 0.0005.*

atorvastatin-fig-2 - atorvastatin fig 2

atorvastatin-fig-2 - atorvastatin fig 2

This is a graph illustrating the cumulative hazard percentage over the course of four years for a placebo and Atorvastatin. The Hazard Ratio (HR) for Atorvastatin is reported as 0.63 with a 95% confidence interval of (0.48-0.83) and a p-value of 0.001. The x-axis corresponds to the time to the first primary endpoint, while the y-axis measures the hazard percentage.*

atorvastatin-fig-3 - atorvastatin fig 3

atorvastatin-fig-3 - atorvastatin fig 3

This is a table that shows the percentage of subjects who experienced a major cardiovascular event after taking different doses of Atorvastatin at different time intervals. The table shows that Atorvastatin 80 mg had a lower rate of cardiovascular events compared to Atorvastatin 10 mg. The HR (Hazard Ratio) for Atorvastatin 80 mg was 0.78 which shows a lower risk of major cardiovascular events. The time to first major cardiovascular endpoint ranged from 1 year to 4 years.*

atorvastatin-st - atorvastatin st

atorvastatin-st - atorvastatin st

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.